Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
The article breaks down the core factors behind price stability in stablecoins, including peg design, reserve backing, and market liquidity.
23,217 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
Investors are torn on Amazon stock as AI hype collides with earnings reality. This guide offers a clear framework to ...
What looks like a bargain today could turn into a meaningful gain by 2026. This guide shows how patient investors ide...
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...
A $50,000 investment can feel like a fork in the road. This guide explains why Amazon stock still has the potential t...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A high-flying semiconductor stock grabbed headlines as it soared. Yet one large investor chose to sell an $89 million...
ETH fell below the $2,000 level, renewing talk of further declines. Market metrics and crowd sentiment suggest the do...